N-(Benzimimdazol-2-yl)-Cyclopropane Carboxamides as Lysophosphatidic Acid Antagonists
申请人:Staehle Wolfgang
公开号:US20140228378A1
公开(公告)日:2014-08-14
The invention provides novel substituted cyclopropane carboxamide compounds according to Formula (I), their manufacture and use for the treatment of proliferative or inflammatory diseases, such as cancer, fibrosis or arthritis.
本发明提供了一种新型的取代环丙烷羧酰胺化合物,其化学式为(I),以及它们的制备方法和用于治疗增生性或炎症性疾病,如癌症、纤维化或关节炎的用途。